GGGrant E. Gochman

Grant E. Gochman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Grant E. Gochman has a total of 40 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Sociodemographic Analysis of Pediatric Patients Undergoing Repeat Tympanostomy Tube Placement

    by Grant E. Gochman, Nina Dharmarajah, Veronica Drozdowski-Nuccio, Richard D. Hubbell

    Objective: The aim of this study is to assess sociodemographic and medical factors associated with repeat bilateral myringotomy with tympanostomy tube placement (rBMT) in the diverse patient population at our academic medical center. Study Design: Retrospective chart review. Setting: Tertiary academic medical center. Methods: A retrospective chart review of pediatric patients seen at a quaternary medical center who underwent BMT was conducted. Demographic, medical, and socioeconomic information was collected. Fisher’s exact test was used to estimate the association between rBMT with all nominal responses. Logistic regression was used to estimate the association between patient variables and rBMT. Results: There were 216 (69% male) patients who underwent rBMT. The mean number of BMT surgeries in those requiring rBMT was 3.09. Black & Hispanic individuals were less likely to undergo rBMT ( P < .05). There were no statistically significant association between social vulnerability index (SVI), type of insurance or distance from the medical center and rBMT ( P > .05). Conclusion: When looking at sociodemographic disparities in those who underwent rBMT, our study demonstrates race and ethnicity were statistically significant factors for decreased likelihood of repeat BMT. SVI, insurance type, and distance from the medical center were not statistically significant in terms of likelihood of rBMT.

  • Analysis of Sociodemographics in Follow-Up Post-Tympanostomy Tube Placement

    by Grant E. Gochman, Veronica Drozdowski-Nuccio, Richard D. Hubbell

    Objective: To determine if disparities exist in patient follow-up post-bilateral myringotomy with tympanostomy tube placement. Introduction: Bilateral myringotomy with tympanostomy tube placement (BMT) is the most common surgery performed in children in the U.S. The current literature suggests there are no demographic differences in treatment of otitis media, however these studies have limited data on postoperative follow-up. This study aims to assess socioeconomic and other factors that affect follow-up after BMT. Methods: A retrospective chart review of pediatric patients seen at a tertiary medical center who underwent BMT was conducted. Demographic, medical, and socioeconomic information was collected. Fisher’s exact test was used to estimate association between follow-up with all nominal responses. Logistic regression was used to estimate association between follow-up with quantitative responses. Results: A total of 750 patients (62.1% male) were included with 37.7% of patients identifying as non-Caucasian and 30.6% as Hispanic. The mean (SD) age at time of surgery was 5.1 (4.4) years. Patients undergoing a concurrent tonsillectomy and adenoidectomy (T&A) were less likely to follow-up than those with BMT alone. This was true even after adjusting for age and distance from medical center (OR = 0.46, 95% CI = 0.27-0.79; P = .01). Race, type of insurance, medical-comorbidities, indication for surgery, and distance from clinic did not affect rate of follow-up ( P > .05). Those who underwent multiple BMTs and those with developmental delay may also be less likely to follow-up, although this finding did not meet statistical significance ( P < .1). Discussion: Our study demonstrates socioeconomic variables, indication for surgery, and co-morbidities were not statistically significant factors in determining rates of follow-up after BMT. Interestingly, concurrent T&A was associated with lower rates of follow-up. Findings in this study suggest large medical centers with diverse patient populations see similar rates of follow-up post-BMT across a variety of variables. Level of Evidence: 3.


  • Open Access

    Idiopathic Subglottic Stenosis in Non‐Caucasian Women

    by Amber Suk, Salem Dehom, Nihal Punjabi, VyVy N. Young, Priya D. Krishna, Lindsay Reder, Karla O'DEll, Grant E. Gochman, Ethan Simmons, Sunil P. Verma, et al.

    Objective: To characterize presentation, disease course, and treatment of idiopathic subglottic stenosis (iSGS) in non‐Caucasian women and compare this cohort to the predominantly female, Caucasian patient cohorts identified in the literature.Study Design: Retrospective review. Results are compared to systematic review of demographics.Setting: Multiple California institutions from 2008 to 2021.Methods: Patients with intubation within 2 years of disease or who met exclusion criteria listed in prior publications were excluded. A systematic review of iSGS patient demographics was also completed for comparison.Results: Of 421 patients with iSGS, 58 self‐identified as non‐Caucasian women, with 50 ultimately included. Mean age of onset was 45.1 years old (95% confidence interval [CI], 41.5‐48.8), and mean age at diagnosis was 47.2 years (95% CI, 43.6‐50.7). Mean Charlson comorbidity index was 1.06 (n = 49, 95% CI, 0.69‐1.44). At diagnosis, Cotton‐Meyer severity scores (documented in n = 45) were Cotton‐Myer (CM) I (28.9%), CM II (40%), and CM III (31.1%). Mean age at first endoscopic surgery was 47.7 (95% CI, 44.2‐51.3) years. 64% experienced disease recurrence with a median of 11 months between their first and second surgery. Our systematic review identified 60 studies that reported demographic features in patients with iSGS. 95% of pooled patients were Caucasian, while other demographic features were similar to the current cohort.Conclusion: The non‐Caucasian population, almost 14% of this Californian cohort, does not differ from the majority Caucasian population detailed in contemporary literature. This cohort supports the presence of some racial and ethnic heterogeneity in this disease population.


  • Comparison of Outcome Measures (Subjective, Objective, and Patient-Based) in Laryngeal Dystonia Treatment With Botulinum Toxin A Injection

    by Christopher D. Dwyer, Grant E. Gochman, Clark A. Rosen, VyVy N. Young, Sarah L. Schneider


  • Assessment of Laryngeal Sensory Function using a Tactile Aesthesiometer in Healthy Adults

    by Yue Ma, Joseph Kidane, Grant E. Gochman, David J. Bracken, Madeleine P. Strohl, Clark A. Rosen, VyVy N. Young

    Introduction: Laryngeal sensory function in healthy adults was assessed through the delivery of tactile stimuli using Cheung-Bearelly monofilaments.Methods: 37 healthy adults were recruited with 340 tactile stimuli analyzed. Four calibrated tactile stimuli were delivered to three laryngeal sites: false vocal fold (FVF), aryepiglottic fold (AEF), and lateral pyriform sinus (LPS). Primary outcome was the elicitation of laryngeal adductor reflex (LAR). Secondary outcomes were gag, patient-reported laryngeal sensation (PRLS), and perceptual strength. Analysis was performed with mixed effects logistic regression modeling.Results: Positive LAR was observed in 35.7%, 70.2%, and 91.2% of stimuli at LPS, AEF, and FVF respectively. LAR rates were significantly associated with laryngopharyngeal subsite (p < 0.001), tactile force (p = 0.001), age (p = 0.022) and sex (p = 0.022). LAR, gag, PRLS, and perceptual strength significantly increased as a more medial laryngeal subsite was stimulated and as stimulus force increased. Each of the ten years of age increase was associated with 19% reduction in odds of LAR (aOR = 0.81, 95% CI [0.68, 0.97]; p = 0.022). Male gender was associated with a 55% reduction in odds of LAR (aOR = 0.45, 95% CI [0.23, 0.89]; p = 0.022).Conclusion: LAR elicitation capability decreases in the male gender, aging, and a more lateral subsite. This study provides insight into the pathophysiology of hypo- and hyper-sensitive laryngeal disorders and is paramount to making accurate diagnostic assessments and finding novel treatment options for various laryngological disorders.


  • Use of Polymeric Nanoparticle Platform Targeting the Liver To Induce Treg-Mediated Antigen-Specific Immune Tolerance in a Pulmonary Allergen Sensitization Model

    by Qi Liu, Xiang Wang, Xiangsheng Liu, Sanjan Kumar, Grant Gochman, Ying Ji, Yu-Pei Liao, Chong Hyun Chang, Wesley Situ, Jianqin Lu, et al.

    Nanoparticles (NPs) can be used to accomplish antigen-specific immune tolerance in allergic and autoimmune disease. The available options for custom-designing tolerogenic NPs include the use of nanocarriers that introduce antigens into natural tolerogenic environments, such as the liver, where antigen presentation promotes tolerance to self- or foreign antigens. Here, we demonstrate the engineering of a biodegradable polymeric poly(lactic-co-glycolic acid) (PLGA) nanocarrier for the selective delivery of the murine allergen, ovalbumin (OVA), to the liver. This was accomplished by developing a series of NPs in the 200–300 nm size range as well as decorating particle surfaces with ligands that target scavenger and mannose receptors on liver sinusoidal endothelial cells (LSECs). LSECs represent a major antigen-presenting cell type in the liver capable of generating regulatory T-cells (Tregs). In vitro exposure of LSECs to NPOVA induced abundant TGF-β, IL-4, and IL-10 production, which was further increased by surface ligands. Animal experiments showed that, in the chosen size range, NPOVA was almost exclusively delivered to the liver, where the colocalization of fluorescent-labeled particles with LSECs could be seen to increase by surface ligand decoration. Moreover, prophylactic treatment with NPOVA in OVA-sensitized and challenged animals (aerosolized inhalation) could be seen to significantly suppress anti-OVA IgE responses, airway eosinophilia, and TH2 cytokine production in the bronchoalveolar lavage fluid. The suppression of allergic airway inflammation was further enhanced by attachment of surface ligands, particularly for particles decorated with the ApoB peptide, which induced high levels of TGF-β production in the lung along with the appearance of Foxp3+ Tregs. The ApoB-peptide-coated NPs could also interfere in allergic airway inflammation when delivered postsensitization. The significance of these findings is that liver and LSEC targeting PLGA NPs could be used for therapy of allergic airway disease, in addition to the potential of using their tolerogenic effects for other disease applications.